SecBot SecBot

To establish in the Department of Defense a program to support the expansion of domestic bioindustrial manufacturing capacity.

H.R. 5187 Rep. Ro Khanna (D-CA-17) In committee
  1. Introduced Sep 8
  2. Committee Sep 8
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Sep 8, 2025Next: House vote
414d ago Sep 8, 2025: Referred to the House Committee on Armed Services.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
2companies, 4 filings
Member trades
1trades in the last 90 days
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

2 companies
Companies by sector
Biotech & Pharma 2
Search all 2 companies, their asks and price moves Subscribe

Summary

This bill authorizes the Secretary of Defense to establish a program to support expanding domestic bioindustrial manufacturing capacity for critical biomanufactured products through competitive awards to private entities for establishing, upgrading, or retooling eligible facilities.

Sec. 1, Bioindustrial Commercialization Program: The Secretary of Defense may, within one year of enactment, create a program to award competitive grants to eligible private entities for establishing, upgrading, or retooling bioindustrial manufacturing facilities in the United States that produce critical biomanufactured products relevant to the Department of Defense.

Award criteria: The Secretary must consider the technology's potential to improve domestic resilience and protect critical supply chains, meet next-generation warfighter needs, the facility's ability to be repurposed and range of products, geographic distribution across the U.S., proximity to input material sources or established biomanufacturing areas, and other appropriate factors.

Use of award funds: Recipients may use funds for establishing, upgrading, or retooling facilities to produce critical biomanufactured products, including developing related business or technical plans.

Oversight: If the program is established, the Secretary must require periodic reports from award recipients on progress, estimated timeline and funding to begin biomanufacturing, products to be produced, and progress in entering agreements with the Department of Defense to supply critical biomanufactured products.

Reports to Congress: Within 90 days of enactment, the Secretary must submit an initial report on the plan for allocating appropriated funds. Annually thereafter, the Secretary must report on program activities, including a list of awards with details on recipients, facility locations, award amounts, criteria supporting awards, rationale for additional amounts, and effects; available funding and plans; communication with applicants; and alignment with Department of Defense priorities and national security.

Sunset: The program terminates 10 years after enactment, but the Secretary may extend it if the President determines continuation is necessary for national economic and national security needs.

Summary of the bill text as introduced in House (Sep 8, 2025), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.